Reducing the trigger dose of recombinant hCG in high-responder patients attending an assisted reproductive technology program: an observational study

Decreasing the dose of human chorionic gonadotropin (hCG) used to trigger final oocyte maturation in assisted reproductive technology programs is regarded as a useful intervention in the prevention of ovarian hyperstimulation syndrome, but the minimal effective dose has not been yet identified. In t...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiboni, Gian Mario, Colangelo, Enrica Concetta, Ponzano, Adalisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876795/
https://www.ncbi.nlm.nih.gov/pubmed/27274202
http://dx.doi.org/10.2147/DDDT.S105607

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876795/
https://www.ncbi.nlm.nih.gov/pubmed/27274202
http://dx.doi.org/10.2147/DDDT.S105607

Ejemplares similares